全国性研究中抗生素使用与结直肠息肉风险相关
在瑞典全国性胃肠病理学ESPRESSO队列中嵌套病例对照研究,纳入45,744例结直肠息肉患者及93,307名未受累同胞对照。中位随访6.9年,抗生素使用者较非使用者结直肠息肉风险升高(OR 1.08,95%CI 1.04-1.13),风险随配药次数增加而升高,广谱抗生素关联强于窄谱。
要点
- 抗生素使用者结直肠息肉风险较非使用者升高(OR 1.08,95%CI 1.04-1.13)。
- ≥6次配药者息肉风险升高更明显(OR 1.33,95%CI 1.25-1.43;Ptrend<.0001)。
- 广谱抗生素关联强于窄谱(OR 1.23 vs 1.05),锯齿状息肉关联强于常规腺瘤。
核心结论
- 在瑞典全国性病例对照研究中,校正遗传和早年环境因素后,抗生素使用与结直肠息肉风险升高相关。
- 作者认为研究结果提示肠道菌群失调在结直肠癌变早期阶段发挥作用。
研究设计与样本
- 在瑞典全国性胃肠病理学ESPRESSO队列中开展嵌套病例对照研究,病例为45,744例结直肠息肉患者,对照为93,307名未受累同胞。
- 通过处方药物登记评估病例及其同胞对照至息肉诊断前1年的抗生素使用及累计配药次数。
主要发现
- 中位研究期6.9年,抗生素使用者包括28,884例病例(63.1%)和53,222名同胞对照(57.0%),其结直肠息肉风险高于非使用者(OR 1.08;95%CI 1.04-1.13)。
- 风险随配药次数增加而升高,≥6次配药者OR 1.33(95%CI 1.25-1.43),Ptrend<.0001。
- 广谱抗生素使用者较非使用者OR 1.23(95%CI 1.18-1.29),窄谱抗生素OR 1.05(95%CI 1.01-1.10)。
- 四环素类和喹诺酮类OR 1.21,青霉素及其他类别OR范围为1.04至1.16。
- 广谱抗生素与锯齿状息肉风险关联(OR 1.29;95%CI 1.21-1.38)强于常规腺瘤(OR 1.17;95%CI 1.11-1.24);结肠与直肠息肉风险无差异(Pheterogeneity>.10)。
关键数值与推荐
- 抗生素使用者较非使用者结直肠息肉风险升高(OR 1.08;95%CI 1.04-1.13)。
- ≥6次抗生素配药者OR 1.33(95%CI 1.25-1.43),Ptrend<.0001。
- 广谱抗生素使用者较非使用者OR 1.23(95%CI 1.18-1.29),窄谱抗生素OR 1.05(95%CI 1.01-1.10)。
- 四环素类和喹诺酮类OR 1.21,青霉素及其他类别OR范围为1.04至1.16。
- 广谱抗生素与锯齿状息肉风险OR 1.29(95%CI 1.21-1.38),与常规腺瘤风险OR 1.17(95%CI 1.11-1.24)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Use of antibiotics affects the composition of the microbiome and might affect development of colorectal polyps, which are precursors to colorectal cancer. METHODS: We performed a nested case-control study in Sweden of 45,744 patients with a colorectal polyp (cases) in the nationwide gastrointestinal ESPRESSO histopathology cohort, using unaffected full siblings as controls (n = 93,307). Polyps were classified by morphology SnoMed codes into conventional adenomas and serrated polyps. Through linkage to the Prescribed Drug Register, we assessed use and cumulative dispensations of antibiotic until 1 year prior to polyp diagnosis for cases and their sibling controls. RESULTS: During a median study period of 6.9 years, compared with non-users, users of antibiotics (including 28,884 cases [63.1%] and 53,222 sibling controls [57.0%]) had a higher risk of colorectal polyps (odds ratio [OR], 1.08; 95% CI, 1.04-1.13). Risk increased with higher number of dispensations (OR for ≥ 6 dispensations, 1.33; 95% CI, 1.25-1.43) (Ptrend < .0001). We observed a stronger association with polyps for broad-spectrum antibiotics (OR comparing users to non-users, 1.23; 95% CI, 1.18-1.29) than for narrow-spectrum antibiotics (OR, 1.05; 95% CI, 1.01-1.10), and for tetracyclines and quinolones (OR, 1.21) than penicillin and other classes (ORs ranged from 1.04 to 1.16). The findings remained robust with several sensitivity analyses, including use of a 2-year lead-in period for antibiotic assessment and correction for misclassification in controls. Use of broad-spectrum antibiotics was more strongly associated with risk of serrated polyps (OR, 1.29; 95% CI, 1.21-1.38) compared with risk of conventional adenomas (OR, 1.17; 95% CI, 1.11-1.24). We found no differences in risk of colon vs rectal polyps with antibiotic use (Pheterogeneity > .10). We found stronger associations for younger (<50 years) vs older adults (≥50 years) for users of quinolones, sulfonamides, trimethoprim, and cephalosporins (Pinteraction < .001). CONCLUSIONS: In a nationwide case-control study in Sweden, after accounting for hereditary and early life environmental factors, antibiotic use was associated with increased risk of colorectal polyps. Our findings indicate a role for intestinal dysbiosis in early stages of colorectal carcinogenesis.
引用
- Song M, Nguyen LH, Emilsson L, et al. Antibiotic Use Associated With Risk of Colorectal Polyps in a Nationwide Study. Clin Gastroenterol Hepatol. 2020. PMID: 32454258. doi:10.1016/j.cgh.2020.05.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。